MIT undertakes Grand Challenge for innovation in global vaccine manufacturing
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Second clinic to take place Thursday, Oct. 20, at the Stratton Student Center.
PhD student Anasuya Mandal’s microneedle device could painlessly monitor the immune system.
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
"It's far easier to scare people than it is to reassure them," MIT researcher and author says.
Study yields insight into generating antibodies that target different strains of HIV.
MIT professor co-authors AAAS report calling for dedicated research on vaccination decisions.
New MIT vaccines that catch a ride to immune cell depots could help fight cancer and HIV.
Research could help prevent millions of people from becoming infected with the next pandemic flu
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
Polymer film that gradually releases DNA coding for viral proteins could offer a better alternative to traditional vaccines.
By deforming cells, researchers can deliver RNA, proteins and nanoparticles for many applications.